Notices. Notice
401 words·~2 min read·
/register/2023/05/04/2023-09401·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4164-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket Nos. FDA-2022-N-1894; FDA-2018-N-3303; FDA-2022-N-0576; FDA-2022-N-1794; FDA-2011-N-0902; FDA-2009-N-0545; FDA-2016-N-2474; FDA-2010-D-0350; FDA-2012-D-0530; FDA-2016-N-2683; FDA-2013-N-0403; FDA-2013-N-0134; FDA-2022-N-2440; FDA-2013-N-0879; and FDA-2014-N-1048] Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration
(FDA)is publishing a list of information collections that have been approved by the Office of Management and Budget
(OMB)under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: JonnaLynn Capezzuto, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-3794, *PRAStaff@fda.hhs.gov.* SUPPLEMENTARY INFORMATION: The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at *https://www.reginfo.gov/public/do/PRAMain.* An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Table 1—List of Information Collections Approved by OMB Title of collection OMB control No. Date approval expires Yale-Mayo Clinic Centers of Excellence in Regulatory Science and Innovation B12 Pediatric Device Survey 0910-0912 3/31/2024 Electronic Products Requirements 0910-0025 2/28/2026 Investigational Device Exemptions 0910-0078 2/28/2026 General Drug Labeling Provisions and OTC Monograph Drug User Fee Submissions 0910-0340 2/28/2026 Prescription Drug Product Labeling; Medication Guide Requirements 0910-0393 2/28/2026 Reporting of Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Product Deviations in Manufacturing 0910-0458 2/28/2026 Designation of New Animal Drugs for Minor Use or Minor Species 0910-0605 2/28/2026 Tobacco Retailer Training Programs 0910-0745 2/28/2026 Q-Submission and Early Payor Feedback Request Programs for Medical Devices 0910-0756 2/28/2026 Data To Support Social and Behavioral Research as Used by the Food and Drug Administration 0910-0847 2/28/2026 Protection of Human Subjects and Institutional Review Boards 0910-0130 3/31/2026 Mammography Standards Quality Act Requirements 0910-0309 3/31/2026 Biologics License Applications; Procedures & Requirements 0910-0338 3/31/2026 Procedures for the Safe Processing and Importing of Fish and Fishery Products 0910-0354 3/31/2026 Medical Device Labeling Regulations; Unique Device Identification 0910-0485 3/31/2026 Dated: April 28, 2023. Lauren K. Roth, Associate Commissioner for Policy. [FR Doc. 2023-09401 Filed 5-3-23; 8:45 am]
Connectionstraces to 1
Traces to 1 document